Issues pertaining to reproductive health and access and coverage of infertility treatments and care as it relates to health equity.
Duration: September 1, 2021
to
December 31, 2023
General Issues: Health Issues , Budget/Appropriations , Defense , Family Issues/Abortion/Adoption
Spending: about $606,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2021: House of Representatives, U.S. Senate, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Tiffany Harris LC, Senator Menendez
Office of Senator Menendez, Judicial LC
Ayshia Connors Senior Policy Advisor, Office of Rep. Brian Fitzpatrick; LC, Office of Rep. Rob Woodall
Gladys Barcena House THUD Appropriations; Office of Rep. Loretta Sanchez; Office of Rep. Linda Sanchez; Office of the House Clerk
Chyna Melton Special Advisor, CISA 2021-2022; Legislative Aide, Office of Rep. Cedric Richmond 2018-2021; Digital Press Secretary, Office of Rep. Val Demings 2018; Legislative Intern, Office of Rep. Cedric Richmond 2017
David Youngblood n/a
Marcus Mason n/a
Marissa Lorenzetti n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2023
The Madison Group terminated an engagement in which they represented Ferring Pharmaceuticals on Jan. 22.
Original Filing: 301536965.xml
Lobbying Issues
Issues pertaining to reproductive health and access and coverage of infertility treatments and care as it relates to health equity.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, The Madison Group lobbied for Ferring Pharmaceuticals , earning $23,000. The report was filed on Oct. 6, 2023.
Original Filing: 301498057.xml
Lobbying Issues
Issues pertaining to reproductive health and access and coverage of infertility treatments and care as it relates to health equity.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, The Madison Group lobbied for Ferring Pharmaceuticals , earning $60,000. The report was filed on July 20, 2023.
Original Filing: 301488606.xml
Lobbying Issues
Issues pertaining to reproductive health and access and coverage of infertility treatments and care.
Issues related to access and coverage for infertility treatment and care for military personnel and military veterans under TriCare.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Defense Appropriations FY2024
Agencies Lobbied
U.S. Senate
Lobbying Issues
NDAA for Fiscal Year 2024; Issues related to access and coverage for infertility treatment and care for military personnel and military veterans under TriCare.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, The Madison Group lobbied for Ferring Pharmaceuticals , earning $60,000. The report was filed on April 19, 2023.
Original Filing: 301457999.xml
Lobbying Issues
Issues pertaining to reproductive health and access and coverage of infertility treatments and care.
Issues related to access and coverage for infertility treatment and care for military personnel and military veterans under TriCare.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Defense Appropriations FY2024
Agencies Lobbied
U.S. Senate
Lobbying Issues
NDAA for Fiscal Year 2024; Issues related to access and coverage for infertility treatment and care for military personnel and military veterans under TriCare.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, The Madison Group lobbied for Ferring Pharmaceuticals , earning $60,000. The report was filed on Jan. 20, 2023.
Original Filing: 301437151.xml
Lobbying Issues
Issues pertaining to reproductive health and access and coverage of infertility treatments and care.
Issues related to infertility treatment and care for military personnel and military veterans under TriCare.
HR 4450/S.2352 - Access to Infertility Treatment and Care Act
H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
H.R.1957 - Veterans Infertility Treatment Act of 2021
H.R.2734/S.1280 - Veteran Families Health Services Act of 2021
H.R.6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act
H.R. 7900, the National Defense Authorization Act (NDAA) for Fiscal Year 2023 (FY23)
H.R.8237 - Legislative Branch Appropriations Act, 2023
H.R.8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023
H.R.4432 - Department of Defense Appropriations Act, 2022
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to reproductive health and access and coverage of infertility treatments and care
Issues related to infertility treatment and care for military personnel and military veterans under TriCare.
HR 4450/S.2352 - Access to Infertility Treatment and Care Act
H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
H.R.1957 - Veterans Infertility Treatment Act of 2021
H.R.2734/S.1280 - Veteran Families Health Services Act of 2021
H.R.6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act
H.R. 7900, the National Defense Authorization Act (NDAA) for Fiscal Year 2023 (FY23)
H.R.8237 - Legislative Branch Appropriations Act, 2023
H.R.8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023
H.R.4432 - Department of Defense Appropriations Act, 2022
Agencies Lobbied
U.S. Senate
Type of Issue
Family Issues/Abortion/Adoption
3rd Quarter, 2022
In Q3, The Madison Group lobbied for Ferring Pharmaceuticals , earning $60,000. The report was filed on Oct. 18, 2022.
Original Filing: 301407330.xml
Lobbying Issues
Issues pertaining to reproductive health and access and coverage of infertility treatments and care.
HR 4450/S.2352 - Access to Infertility Treatment and Care Act
H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
H.R.1957 - Veterans Infertility Treatment Act of 2021
H.R.2734/S.1280 - Veteran Families Health Services Act of 2021
H.R.6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act
H.R. 7900, the National Defense Authorization Act (NDAA) for Fiscal Year 2023 (FY23)
H.R.8237 - Legislative Branch Appropriations Act, 2023
H.R.8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023
H.R.4432 - Department of Defense Appropriations Act, 2022
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to reproductive health and access and coverage of infertility treatments and care
HR 4450/S.2352 - Access to Infertility Treatment and Care Act
H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
H.R.1957 - Veterans Infertility Treatment Act of 2021
H.R.2734/S.1280 - Veteran Families Health Services Act of 2021
H.R.6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act
H.R. 7900, the National Defense Authorization Act (NDAA) for Fiscal Year 2023 (FY23)
H.R.8237 - Legislative Branch Appropriations Act, 2023
H.R.8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023
H.R.4432 - Department of Defense Appropriations Act, 2022
Agencies Lobbied
U.S. Senate
Type of Issue
Family Issues/Abortion/Adoption
2nd Quarter, 2022
In Q2, The Madison Group lobbied for Ferring Pharmaceuticals , earning $60,000. The report was filed on July 20, 2022.
Original Filing: 301389567.xml
Lobbying Issues
Issues pertaining to reproductive health and infertility access and treatment
HR 4450/S.2352 - Access to Infertility Treatment and Care Act
H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
H.R.1957 - Veterans Infertility Treatment Act of 2021
H.R.2734/S.1280 - Veteran Families Health Services Act of 2021
H.R.6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act
H.R. 7900, the National Defense Authorization Act (NDAA) for Fiscal Year 2023 (FY23)
H.R.8237 - Legislative Branch Appropriations Act, 2023
H.R.8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023
H.R.4432 - Department of Defense Appropriations Act, 2022
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to reproductive health and infertility access and treatment
HR 4450/S.2352 - Access to Infertility Treatment and Care Act
H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
H.R.1957 - Veterans Infertility Treatment Act of 2021
H.R.2734/S.1280 - Veteran Families Health Services Act of 2021
H.R.6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act
H.R. 7900, the National Defense Authorization Act (NDAA) for Fiscal Year 2023 (FY23)
H.R.8237 - Legislative Branch Appropriations Act, 2023
H.R.8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023
H.R.4432 - Department of Defense Appropriations Act, 2022
Agencies Lobbied
U.S. Senate
Type of Issue
Family Issues/Abortion/Adoption
1st Quarter, 2022
In Q1, The Madison Group lobbied for Ferring Pharmaceuticals , earning $20,000. The report was filed on April 20, 2022.
Original Filing: 301369411.xml
Lobbying Issues
issues pertaining to maternal health and infertility access and treatment
HR 4450/S.2352 - Access to Infertility Treatment and Care Act
H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
H.R.1957 - Veterans Infertility Treatment Act of 2021
H.R.2734/S.1280 - Veteran Families Health Services Act of 2021
H.R.6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
issues pertaining to maternal health and infertility access and treatment -
HR 4450/S.2352 - Access to Infertility Treatment and Care Act
H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
H.R.1957 - Veterans Infertility Treatment Act of 2021
H.R.2734/S.1280 - Veteran Families Health Services Act of 2021
H.R.6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act
Agencies Lobbied
U.S. Senate
Type of Issue
Family Issues/Abortion/Adoption
4th Quarter, 2021
In Q4, The Madison Group lobbied for Ferring Pharmaceuticals , earning $120,000. The report was filed on Jan. 20, 2022.
Original Filing: 301333913.xml
Lobbying Issues
Issues pertaining to maternal health and infertility access and treatment
HR 4450 - Access to Infertility Treatment and Care Act
H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
H.R.1957 - Veterans Infertility Treatment Act of 2021
H.R.2734 - Veteran Families Health Services Act of 2021
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to maternal health and infertility access and treatment
HR 4450 - Access to Infertility Treatment and Care Act
H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
H.R.1957 - Veterans Infertility Treatment Act of 2021
H.R.2734 - Veteran Families Health Services Act of 2021
Agencies Lobbied
U.S. Senate
Type of Issue
Family Issues/Abortion/Adoption
3rd Quarter, 2021
In Q3, The Madison Group lobbied for Ferring Pharmaceuticals , earning $120,000. The report was filed on Oct. 20, 2021.
Original Filing: 301311971.xml
Lobbying Issues
Issues pertaining to maternal health and infertility access and treatment
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...